2019
BioMed and Collaborator Chemveda Life Sciences Enter Agreement for Synthesis and Manufacturing of Liver Cancer Chemotherapeutic.
Sept. 11, 2019
BioMed and Collaborator Chemveda Life Sciences Enter Agreement for Synthesis and Manufacturing of Liver Cancer Chemotherapeutic.
Chemveda Life Sciences and Q BioMed, Inc. Announce Potential Chemotherapeutic Breakthrough in Liver Cancer
Professor K.C. Nicolaou visits Chemveda Life Sciences
Dr. Bheema Paraselli, CEO, Chemveda Life Sciences attends the OMRF BioVenture Forum